A Study With IPX056 in Subjects With Spasticity Associated With Multiple Sclerosis

Clinical trial NCT00914290 · COMPLETED

Trial details

NCT number: NCT00914290
Sponsor: Impax Laboratories, LLC
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Spasticity Multiple Sclerosis

Start date: 2009-04-01
Primary completion: 2010-01-01
Enrollment: 23

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.